Skip to main content

Oncology

Lung Cancer, Oncology
Alectinib Potential First-Line Treatment for NSCLC Associated with ALK Mutation
Wayne Kuznar
Read More
In the Literature, Prostate Cancer, Oncology
In the Literature - August 2016
Read More
In the News, Lung Cancer, Oncology
New Data Show Osimertinib Effective as First-Line Treatment of NSCLC with EGFR Mutation
Lilly Ostrovsky
Lilly Ostrovsky
Read More
Multiple Myeloma, Oncology
Multiple Myeloma Therapy in 2015: “An Extraordinary Moment in Oncology”
Dana Taylor
Read More
Multiple Myeloma, Oncology
All-Oral Regimen May Become a New Standard of Care in Advanced Multiple Myeloma
Dana Taylor
Read More
Multiple Myeloma, Oncology
Consistent Benefit Over Time in Elotuzumab Studies
Dana Taylor
Read More
Multiple Myeloma, Oncology
Daratumumab Improves Overall Survival in Multiple Myeloma
Dana Taylor
Read More
Leukemia, Oncology
Nilotinib Yields Better Rates of Molecular Response Than Imatinib in Frontline Setting
Chase Doyle
Read More
Leukemia, Oncology
Ibrutinib a New Standard of Care for Elderly Patients with Chronic Lymphocytic Leukemia
Phoebe Starr
Read More
Leukemia, Oncology
Idelalisib Improves Survival When Added to Bendamustine plus Rituximab in Patients with CLL
Phoebe Starr
Read More
Page 18 of 27
Results 171 - 180 of 262